Correction for Zhou et al., “Neutralization Titers in Vaccinated Patients with SARS-CoV-2 Delta Breakthrough Infections”

Correction for Zhou et al., “Neutralization Titers in Vaccinated Patients with SARS-CoV-2 Delta Breakthrough Infections”

Bibliographic Details
Main Authors:	Jing Zou, Xuping Xie, Mingru Liu, Pei-Yong Shi, Ping Ren
Format:	Article
Language:	English
Published:	American Society for Microbiology 2022-12-01
Series:	mBio
Online Access:	https://journals.asm.org/doi/10.1128/mbio.03108-22

Similar Items

Neutralization Titers in Vaccinated Patients with SARS-CoV-2 Delta Breakthrough Infections
by: Jing Zou, et al.
Published: (2022-08-01)

Cross-neutralization of Omicron BA.1 against BA.2 and BA.3 SARS-CoV-2
by: Jing Zou, et al.
Published: (2022-05-01)

Assessment of SARS-CoV-2 neutralizing antibody titers in breastmilk from convalescent and vaccinated mothers
by: Christine Bäuerl, et al.
Published: (2023-06-01)

Neutralization of Omicron sublineages and Deltacron SARS-CoV-2 by three doses of BNT162b2 vaccine or BA.1 infection
by: Chaitanya Kurhade, et al.
Published: (2022-12-01)

SARS-CoV-2 Vaccine Breakthrough Infections of Omicron and Delta Variants in Healthcare Workers
by: Elisa Regenhardt, et al.
Published: (2023-05-01)

Anti-SARS-CoV-2 Spike Antibody Titers and Neutralizing Antibodies in Vaccinated Rheumatoid Arthritis Patients
by: Hiroshi Furukawa, et al.
Published: (2022-08-01)

Clinical characteristics and immune profile alterations in vaccinated individuals with breakthrough Delta SARS-CoV-2 infections
by: Qinghong Fan, et al.
Published: (2022-07-01)

Author Correction: High monoclonal neutralization titers reduced breakthrough HIV-1 viral loads in the Antibody Mediated Prevention trials
by: Daniel B. Reeves, et al.
Published: (2024-03-01)

A Single-Round Infection Fluorescent SARS-CoV-2 Neutralization Test for COVID-19 Serological Testing at a Biosafety Level-2 Laboratory
by: Jing Zou, et al.
Published: (2022-06-01)

Breakthrough infections due to SARS-CoV-2 Delta variant: relation to humoral and cellular vaccine responses
by: Matthieu Buscot, et al.
Published: (2023-03-01)

Comparative neutralization profiles of naive and breakthrough infections with Delta, Omicron BA.1 and BA.2 variants of SARS-CoV-2
by: Yang Yang, et al.
Published: (2022-09-01)

Correlation between Commercial Anti-RBD IgG Titer and Neutralization Titer against SARS-CoV-2 Beta Variant
by: Rosana Wing-Shan Poon, et al.
Published: (2021-11-01)

Vaccine breakthrough infection leads to distinct profiles of neutralizing antibody responses by SARS-CoV-2 variant
by: Michael S. Seaman, et al.
Published: (2022-10-01)

Author Correction: Titers of antibodies against ancestral SARS-CoV-2 correlate with levels of neutralizing antibodies to multiple variants
by: Trung The Tran, et al.
Published: (2023-01-01)

Predicting Vaccine Effectiveness for Hospitalization and Symptomatic Disease for Novel SARS-CoV-2 Variants Using Neutralizing Antibody Titers
by: Billy J. Gardner, et al.
Published: (2024-03-01)

COVID-19 vaccine induced poor neutralization titers for SARS-CoV-2 omicron variants in maternal and cord blood
by: Sakthivel Govindaraj, et al.
Published: (2023-07-01)

Analysis of anti-SARS-CoV-2 Omicron-neutralizing antibody titers in different vaccinated and unvaccinated convalescent plasma sources
by: David J. Sullivan, et al.
Published: (2022-10-01)

Longitudinal antibody titer, avidity, and neutralizing responses after SARS-CoV-2 infection
by: Jonathon M. Monroe, et al.
Published: (2022-11-01)

An observational study of breakthrough SARS-CoV-2 Delta variant infections among vaccinated healthcare workers in Vietnam
by: Chau, NVV, et al.
Published: (2021)

Enhanced virulence and waning vaccine-elicited antibodies account for breakthrough infections caused by SARS-CoV-2 delta and beyond
by: Hyung-Joon Kwon, et al.
Published: (2022-12-01)

Impact of hybrid immunity booster vaccination and Omicron breakthrough infection on SARS-CoV-2 VOCs cross-neutralization
by: Edwards Pradenas, et al.
Published: (2023-04-01)

Broad and potent neutralizing antibodies are elicited in vaccinated individuals following Delta/BA.1 breakthrough infection
by: Jeffrey Seow, et al.
Published: (2023-10-01)

Increased body mass index linked to decreased neutralizing antibody titers of inactivated SARS‐CoV‐2 vaccine in healthcare workers
by: Juan Hu, et al.
Published: (2023-02-01)

Direct capture of neutralized RBD enables rapid point-of-care assessment of SARS-CoV-2 neutralizing antibody titer
by: Connelly, Guinevere G, et al.
Published: (2023)

High monoclonal neutralization titers reduced breakthrough HIV-1 viral loads in the Antibody Mediated Prevention trials
by: Daniel B. Reeves, et al.
Published: (2023-12-01)

Breakthrough infections with the omicron and delta variants of SARS-CoV-2 result in similar re-activation of vaccine-induced immunity
by: Arne Søraas, et al.
Published: (2022-09-01)

Symptomatic SARS-CoV-2 breakthrough with delta variant after 3rd mRNA vaccine shot (booster)
by: Verena Schildgen, et al.
Published: (2022-04-01)

A study of SARS-CoV-2 delta variant breakthrough infections and side effects of the Oxford-AstraZeneca vaccine
by: Nawfal R. Hussein, et al.
Published: (2022-12-01)

Virological and serological kinetics of SARS-CoV-2 Delta variant vaccine breakthrough infections: a multicentre cohort study
by: Chia, Po Ying, et al.
Published: (2022)

Author Correction: Higher Delta variant-specific neutralizing antibodies prevented infection in close contacts vaccinated with ancestral mRNA vaccines during the SARS-CoV-2 Delta wave
by: Yun Shan Goh, et al.
Published: (2024-01-01)

SARS-CoV-2 Vaccine Alpha and Delta Variant Breakthrough Infections Are Rare and Mild but Can Happen Relatively Early after Vaccination
by: Jelissa Katharina Peter, et al.
Published: (2022-04-01)

Predictors of Breakthrough SARS-CoV-2 Infection after Vaccination
by: Sharon Walmsley, et al.
Published: (2023-12-01)

Correlation of SARS-CoV-2 Viral Neutralizing Antibody Titers with Anti-Spike Antibodies and ACE-2 Inhibition among Vaccinated Individuals
by: Brian Grunau, et al.
Published: (2022-10-01)

Computation of Antigenicity Predicts SARS-CoV-2 Vaccine Breakthrough Variants
by: Ye-Fan Hu, et al.
Published: (2022-03-01)

Titers of antibodies against ancestral SARS-CoV-2 correlate with levels of neutralizing antibodies to multiple variants
by: Trung The Tran, et al.
Published: (2022-12-01)

Erratum: Breakthrough infections with the omicron and delta variants of SARS-CoV-2 result in similar re-activation of vaccine-induced immunity
by: Frontiers Production Office
Published: (2023-07-01)

Less neutralization evasion of SARS-CoV-2 BA.2.86 than XBB sublineages and CH.1.1
by: Yanping Hu, et al.
Published: (2023-12-01)

The effect of SARS-CoV-2 D614G mutation on BNT162b2 vaccine-elicited neutralization
by: Jing Zou, et al.
Published: (2021-03-01)

Kinetics of SARS-CoV-2 neutralizing antibodies in Omicron breakthrough cases with inactivated vaccination: Role in inferring the history and duration of infection
by: Aidibai Simayi, et al.
Published: (2023-01-01)

Low Neutralizing Antibody Titers against the Mu Variant of SARS-CoV-2 in 31 BNT162b2 Vaccinated Individuals in Colombia
by: Diego A. Álvarez-Díaz, et al.
Published: (2022-01-01)